Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA

Laufey Amundadottir

Laboratory of Translational Genomics - Amundadottir

Prostate Pancreas

Pathology

Samuel I Gunderson

Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer

Pancreas

Keping Xie

Molecular Mediators of Pancreatic Cancer Invasion and Progression

Pancreas

Pathology

Kathleen M Mulder

Directional Motility and ERM Scaffolding in Pathfinder Pancreatic Carcinoma Cells

Pancreas

Pathology

Alison P Klein

Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci

Pancreas

Pathology

Peng Wei

Genetic Susceptibility and Risk Model for Pancreatic Cancer

Pancreas

Pathology

Jonathan F Lovell

Light-Triggered Drug Release in Primed Pancreatic Tumors

Pancreas

Antoinette Stroup

CORE INFRASTURCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER)PERIOD OF PERFORMANCE

Trachea, bronchus and lung Pancreas Kidney, renal pelvis and ureter Colorectum Breast Bladder

Stephen G Emerson

Palliative care and end-of-life issues among cancer patients in Soweto, South Africa

Trachea, bronchus and lung Pancreas Oesophagus Liver and intrahepatic bile ducts Colorectum Breast